1. Home
  2. ORMP

ORMP

Oramed Pharmaceuticals Inc.

Logo Oramed Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 10:31am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Founded: 2002 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 109.0M IPO Year: N/A
Target Price: $2.00 AVG Volume (30 days): 174.4K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.14 EPS Growth: N/A
52 Week Low/High: $1.67 - $5.25 Next Earning Date: 05-09-2024
Revenue: $1,340,000 Revenue Growth: -50.43%
Revenue Growth (this year): -1.04% Revenue Growth (next year): N/A

Share on Social Networks: